Company expands precision oncology pipeline with licensing of CRB-701, clinical-stage Nectin-4 antibody drug conjugate (ADC) from CSPC Pharmaceutical Group
CRB-701 Phase 1 dose escalation ongoing in
Form 10-K Corbus Pharmaceuticals For: Dec 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced the appointment.
Corbus Pharma (CRBP) Appoints Yong Ben to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
杨力教授:千古英雄赋_中华网 china.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from china.com Daily Mail and Mail on Sunday newspapers.